Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
411 *
|
Wed, 8/10/2022,
10:30 AM -
12:20 PM
|
CC-158AB
|
|
Addressing Key Issues to Promote the Uptake of Using RWE/D for Regulatory Decisions — Topic Contributed Papers
|
|
Biopharmaceutical Section, Stats. Partnerships Among Academe Indust. & Govt. Committee, Health Policy Statistics Section
|
|
Organizer(s): Yixin Fang, AbbVie
|
|
Chair(s): Hana Lee, FDA
|
|
10:35 AM
|
Estimands in Real-World Studies
Jie Chen, Overland Pharmaceuticals
|
|
10:55 AM
|
Statistical Consideration for Fit-For-Use Real-World Data to Support Regulatory Decision Making in Drug Development
Weili He, AbbVie
|
|
11:15 AM
|
Sensitivity Analyses for Unmeasured Confounding: A Path Forward?
Douglas Faries, Eli Lilly & Company
|
|
11:35 AM
|
Examples of Applying Causal Inference Framework in Real-World Settings
Yixin Fang, AbbVie
|
|
11:55 AM
|
Discussant: Mark Levenson, FDA
|
|
12:15 PM
|
Floor Discussion
|
Video Available to all JSM Registered Attendees. Please login to view.
|
